brazen22, Thank you—this is a bit of progress! Dr. Malkin has some conflicts as I believe he’s involved in developing other GBM treatments, but his views are still valid as the opinion of one individual.
I saw the interview and I think he’s making the case for phase 4 investigation. Data should be gathered for all newly commercialized drugs and I think any physician would support further investigation.
He commented on only one of the clinical trials involving DCVax-L, and I would be interested to hear his commentary on the others, especially since the release of the interim survival data for the pembrolizumab combo study that is ongoing at UCLA today.
"Malkin will spend nearly half of his time on translational research, trying to develop novel ideas into better treatment options" (treating brain tumors}